Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants - Nature

Brasil Notícia Notícia

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants - Nature
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Nature
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 68%

Nature research paper: Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.Omicron, the most heavily mutated SARS-CoV-2 variant so far, is highly resistant to neutralizing antibodies, raising unprecedented concerns about the effectiveness of antibody therapies and vaccines.

Kang Wang, Zijing Jia, Lei Wang, Lei Cao, Qianhui Zhu, Pan Liu, Nan Wang, Boling Zhu, Kaiyue Fan, Wangjun Fu, Peng Yang, Xinran Pei, Zhen Cui & Xiangxi Wang Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, ChinaLei Wang, Qianhui Zhu, Kaiyue Fan, Wangjun Fu, Peng Yang, Zhen Cui & Xiangxi...

State Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, ChinaYaling Hu, Lin Wang, Min Liu & Yurong Li Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control , Beijing, ChinaYinan Jiang, Lili Qin, Pingju Ge & Yiding Chen

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Nature /  🏆 64. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in IsraelVaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
Consulte Mais informação »

Indirect protection of children from SARS-CoV-2 infection through parental vaccinationIndirect protection of children from SARS-CoV-2 infection through parental vaccinationChildren unvaccinated against SARS-CoV-2 may still benefit through protection from vaccinated contacts. We estimated the protection provided to children through parental vaccination with the BNT162b2 vaccine. We studied households without prior infection, ...
Consulte Mais informação »

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humansThe SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humansAn antibody therapy for COVID19 both prevents and treats SARSCoV2 infections—including with some variants of concern—in large animals, and shows promising activity and extended half-life in human volunteers. ScienceTM
Consulte Mais informação »

'Jackass Forever' Video Takes Us On a Nostalgic Trip Down a Wild Memory Lane'Jackass Forever' Video Takes Us On a Nostalgic Trip Down a Wild Memory LaneA new 'Jackass Forever' video revisits why the franchise has endured for so long.
Consulte Mais informação »

Faithful photographer: A snapshot of 49ers' memory-keeper during 2021 playoff runFaithful photographer: A snapshot of 49ers' memory-keeper during 2021 playoff runWe go behind the lens with the 49ers Director of Photography who has captured some of the most iconic moments for the red and gold.
Consulte Mais informação »

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humansThe SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humansAn antibody therapy for COVID19 both prevents and treats SARSCoV2 infections—including with some variants of concern—in large animals, and shows promising activity and extended half-life in human volunteers. ScienceTM
Consulte Mais informação »



Render Time: 2025-03-05 01:10:44